Header Logo
Last Name

Genevieve A Laforet MD, PhD

TitleAssistant Professor
InstitutionUniversity of Massachusetts Medical School
Address45 William Street, Suite 200
Wellesley MA 02481
vCardDownload vCard
    Other Positions
    InstitutionUMMS - School of Medicine

    Collapse Biography 
    Collapse education and training
    Harvard University, Cambridge, MA, United StatesBABiochemical Sciences
    Duke University, Durham, NC, United StatesMD
    The Rockefeller University, New York, NY, United StatesPHDBioorganic Chem & Biochem

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Varsanik JS, Kimmel ZM, Laforet GA, Ricotti V, Sajeev G, Signorovitch J, Quiroz JA, Chevalier TW. Validation of an ambient measurement system (AMS) for physical activities in a paediatric population. J Med Eng Technol. 2019 Jul 15; 1-8. PMID: 31305192.
      View in: PubMed
    2. Kinkel RP, Laforet G, You X. Disease-related determinants of quality of life 10 years after clinically isolated syndrome. Int J MS Care. 2015 Jan-Feb; 17(1):26-34. PMID: 25741224.
      View in: PubMed
    3. Scott TF, Laforet G, You X. Aggressive relapsing multiple sclerosis characterized by rapid disability progression. Mult Scler Relat Disord. 2013 Oct; 2(4):370-6. PMID: 25877848.
      View in: PubMed
    4. Fox RJ, Salter AR, Tyry T, Sun J, You X, Laforet G, Campagnolo D. Treatment discontinuation and disease progression with injectable disease-modifying therapies: findings from the north american research committee on multiple sclerosis database. Int J MS Care. 2013; 15(4):194-201. PMID: 24453783.
      View in: PubMed
    5. Llano DA, Laforet G, Devanarayan V. Derivation of a new ADAS-cog composite using tree-based multivariate analysis: prediction of conversion from mild cognitive impairment to Alzheimer disease. Alzheimer Dis Assoc Disord. 2011 Jan-Mar; 25(1):73-84. PMID: 20847637.
      View in: PubMed
    6. Apostol G, Pakalnis A, Laforet GA, Robieson WZ, Olson E, Abi-Saab WM, Saltarelli M. Safety and tolerability of divalproex sodium extended-release in the prophylaxis of migraine headaches: results of an open-label extension trial in adolescents. Headache. 2009 Jan; 49(1):36-44. PMID: 19040678.
      View in: PubMed
    7. Apostol G, Lewis DW, Laforet GA, Robieson WZ, Fugate JM, Abi-Saab WM, Saltarelli MD. Divalproex sodium extended-release for the prophylaxis of migraine headache in adolescents: results of a stand-alone, long-term open-label safety study. Headache. 2009 Jan; 49(1):45-53. PMID: 19040679.
      View in: PubMed
    8. Apostol G, Cady RK, Laforet GA, Robieson WZ, Olson E, Abi-Saab WM, Saltarelli M. Divalproex extended-release in adolescent migraine prophylaxis: results of a randomized, double-blind, placebo-controlled study. Headache. 2008 Jul; 48(7):1012-25. PMID: 18705027.
      View in: PubMed
    9. Akbarian S, Jiang Y, Laforet G. The molecular pathology of Rett syndrome: synopsis and update. Neuromolecular Med. 2006; 8(4):485-94. PMID: 17028371.
      View in: PubMed
    For assistance with using Profiles, please refer to the online tutorials or contact UMMS Help Desk or call 508-856-8643.
    Laforet's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    Similar People Expand Description
    Same Department Expand Description